The cocaine-like behavioral effects of meperidine are mediated by activity at the dopamine transporter

被引:19
|
作者
Izenwasser, S [1 ]
Newman, AH [1 ]
Cox, BM [1 ]
Katz, JL [1 ]
机构
[1] UNIFORMED SERV UNIV HLTH SCI,DEPT PHARMACOL,BETHESDA,MD 20814
基金
美国国家卫生研究院;
关键词
dopamine transporter; cocaine; meperidine;
D O I
10.1016/0014-2999(95)00696-6
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Meperidine has atypical opioid receptor agonist effects and shares some structural features with the phenyltropane (WIN) analogs of cocaine. In combination with 0.1 mg/kg naltrexone, meperidine produced cocaine-like discriminative stimulus effects in monkeys, whereas morphine was inactive. Both cocaine and meperidine inhibited [H-3]dopamine uptake in chopped rat caudate putamen with comparable potencies; meperidine differed from cocaine in that its effects could be characterized as having predominantly a single high-affinity component. Morphine was not active in inhibiting [H-3]dopamine uptake, indicating that the effect of meperidine was not via a classic mu-opioid receptor agonist action. Further, meperidine but not morphine displaced [H-3]WIN 35,428 (2 beta-carbomethoxy-3 beta-(4-fluorophenyl)tropane) binding. These data suggest that the actions of meperidine that are atypical of opioids are due to activity at the dopamine transporter. In addition, meperidine appears to interact predominantly with the high-affinity component of the dopamine transporter, and this high-affinity component may be the site of importance for the production of cocaine's behavioral effects.
引用
收藏
页码:9 / 17
页数:9
相关论文
共 50 条
  • [31] Cocaine effects on dopamine transporter mRNA in human users
    Little, KY
    McLaughlin, DP
    McFinton, PR
    Livermore, CS
    Watson, SJ
    Cassin, BP
    [J]. BIOLOGICAL PSYCHIATRY, 1996, 39 (07) : 459 - 459
  • [32] Assessment of the influence of histaminergic actions on cocaine-like effects of 3α-diphenylmethoxytropane analogs
    Campbell, VC
    Kopajtic, TA
    Newman, AH
    Katz, JL
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2005, 315 (02): : 631 - 640
  • [33] Cocaine-like discriminative stimulus effects and [3H]dopamine uptake inhibition produced by selected partial opioid agonists
    Barrett, AC
    Morgan, D
    Izenwasser, S
    Picker, MJ
    [J]. BEHAVIOURAL PHARMACOLOGY, 2001, 12 (04): : 225 - 235
  • [34] Synthesis of 8-oxa analogues of norcocaine endowed with interesting cocaine-like activity
    Kozikowski, AP
    Simoni, D
    Roberti, M
    Rondanin, R
    Wang, SM
    Du, PF
    Johnson, KM
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (13) : 1831 - 1836
  • [35] Behavioral and neurochemical effects of the dopamine transporter ligand 4-chlorobenztropine alone and in combination with cocaine in vivo
    Tolliver, BK
    Newman, AH
    Katz, JL
    Ho, LB
    Fox, LM
    Hsu, K
    Berger, SP
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1999, 289 (01): : 110 - 122
  • [36] D-amphetamine maintenance treatment goes a long way: lasting therapeutic effects on cocaine behavioral effects and cocaine potency at the dopamine transporter
    Emily M. Black
    Rodrigo A. España
    [J]. Neuropsychopharmacology, 2021, 46 : 275 - 276
  • [37] D-amphetamine maintenance treatment goes a long way: lasting therapeutic effects on cocaine behavioral effects and cocaine potency at the dopamine transporter
    Black, Emily M.
    Espana, Rodrigo A.
    [J]. NEUROPSYCHOPHARMACOLOGY, 2021, 46 (02) : 275 - 276
  • [38] Cocaine-induced behavioral sensitization is associated with reduced dopamine transporter activity in freely moving rats.
    Sabeti, J
    Gerhardt, GA
    Zahniser, NR
    [J]. FASEB JOURNAL, 2000, 14 (08): : A1550 - A1550
  • [39] Differential effects of dopamine transporter inhibitors on cocaine-stimulated dopamine neurotransmission
    Tanda, G
    Ebbs, AL
    Newman, AH
    Katz, JL
    [J]. FASEB JOURNAL, 2006, 20 (04): : A676 - A676
  • [40] Relations between heterogeneity of dopamine transporter binding and function and the behavioral pharmacology of cocaine
    Katz, JL
    Newman, AH
    Izenwasser, S
    [J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1997, 57 (03) : 505 - 512